Alex Llobet-Del Pino

Alex Llobet-Del Pino

Auto-generated profile, based on publicly available information

Alex Llobet-Del Pino


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IGIrene García-Jiménez
Irene García-Jiménez
IFIgnasi Figueras-Nart
Ignasi Figueras-Nart
LNLídia Sans-De San Nicolás
Lídia Sans-De San Nicolás
LBLaia Curto Barredo
Laia Curto Barredo
MBMarta Bertolín-Colilla
Marta Bertolín-Colilla
LSLuis F Santamaria-Babi
Luis F Santamaria-Babi
Lactate dehydrogenase (LDH) is a serum biomarker well known to correlate with disease severity in atopic dermatitis (AD). The aim of this study was to explore the cutaneous immune responses and the clinical profile of AD patients in relation to serum LDH levels. To this end, 47 untreated, adult patients with moderate-to-severe AD were stratified by median levels of serum LDH. Circulating memory T-cell responses to house dust mite (HDM) extract, in the presence of autologous lesional epidermal cells, were compared between AD subgroups. The LDHhigh group exhibited significantly higher IL-13, IL-5 and IL-9 in vitro responses confined to the cutaneous lymphocyte-associated antigen (CLA)+ subset compared to LDHlow patients. Clinically, LDHhigh patients were younger and exhibited more severe disease, elevated eosinophil counts in their blood, increased total and specific IgE levels in their plasma, and a higher prevalence of allergic rhinitis. Our data suggests that high LDH levels identify a subgroup of AD patients with a specific immune and clinical profile, and highlight the potential of LDH as a clinical parameter that may enable patient stratification for treatment selection.